DOI: 10.12890/2021_002204
COVID-19 in a Patient Newly Diagnosed with AIDS: Asymptomatic Disease
Authors
manusrsm@gmail.com
Keywords
COVID-19, SARS-CoV-2, HIV, AIDS, immunosuppressionAbstract
The COVID-19 pandemic has imposed new challenges to scientific community. It’s behaviour and outcomes in people living with HIV is not yet well studied. We report a case of a 34-year-old-male with a newly diagnosed HIV infection stage 4 and asymptomatic SARS-CoV-2 infection. Although immunocompromised patients are classified as a high risk group for developing severe COVID-19, HIV related immunosuppression may have a protective role.
References
- World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Geneva: World Health Organization; 2020. Available at https://covid19.who.int/ (accessed 13 Jan 2021).
- Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS 2020;34(12):1775–1780.
- Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis 2020 Jun 27;ciaa863. doi: 10.1093/cid/ciaa863. Online ahead of print.
- Xiao T, Wang Y, Yuan J, Ye H, Wei L, Liao X, et al. Early viral clearance and antibody kinetics of COVID-19 among asymptomatic carriers. medRxiv May 02, 2020; doi: https://doi.org/10.1101/2020.04.28.20083139.